One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy
NCT06809491
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Melanoma, Skin
Adjuvant Treatment
Sponsor
Central Hospital, Nancy, France